A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer Meeting Abstract
| Authors: | Lim, S.; Moss, H.; Havrilesky, L.; O'Cearbhaill, R.; Abu-Rustum, N.; Liang, M.; Wright, J.; Aviki, E. |
| Abstract Title: | A novel, out-of-pocket, cost-effectiveness analysis comparing a frontline niraparib-for-all to a biomarker-based strategy in patients with advanced ovarian cancer |
| Meeting Title: | 2021 Society of Gynecologic Oncology - 52nd Annual Meeting on Women's Cancer |
| Journal Title: | Gynecologic Oncology |
| Volume: | 162 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Mar 19-25 |
| Meeting Location: | Virtual |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-08-01 |
| Start Page: | S77 |
| Language: | English |
| ACCESSION: | WOS:000687070800132 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0090-8258(21)00786-1 |
| Notes: | Meeting Abstract: 135 -- Source: Wos |
